undamentalytics Newsletter

Mukunda Ram: insider trades

Chief executive at IGC Pharma, Inc. No open-market purchases and 7 sales not made under a pre-set plan, reported from December 8, 2017 to March 8, 2021.

What happened after Mukunda Ram’s sales?

None of these trades can be measured yet: either the window after the report has not finished or the share price was under $5 when it was reported.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Mukunda Ram: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
IGC Pharma, Inc. IGC Exec. Chairman & CEO07December 8, 2017March 8, 2021

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 8, 2021March 2, 2021 IGC Sale $107,000 not yetnot yetnot yet
December 2, 2020November 30, 2020 IGC Sale $187,200 not yetnot yetnot yet
August 31, 2018August 30, 2018 IGC Sale $93,500 not yetnot yetnot yet
August 29, 2018August 22, 2018 IGC Sale $207,250 not yetnot yetnot yet
January 12, 2018January 10, 2018 IGC Sale $39,162 not yetnot yetnot yet
December 18, 2017December 14, 2017 IGC Sale $37,750 not yetnot yetnot yet
December 8, 2017December 7, 2017 IGC Sale $132,908 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Mukunda Ram traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.